U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Dietary Prevention of Obesity-related Disease Research: Grand Forks, ND
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Plains Area Grand Forks, North Dakota Grand Forks Human Nutrition Research Center Dietary Prevention of Obesity-related Disease Research Research Publications at this Location





- ARS National Programs
- Search for a scientific manuscript
- Search for a research project
- ARS Software
- Programs and Projects
- Collaborations
- Subjects of Investigation
- Publications

Title:   Author  item
                                            YUAN, XUE - State University Of New York (SUNY)item
                                            Cao, Jayitem
                                            LIU, TONGJUN - State University Of New York (SUNY)item
                                            LI, YI-PING - University Of Alabamaitem
                                            SCANNAPIECO, FRANK - State University Of New York (SUNY)item
                                            HE, XIAONING - China Medical Universityitem
                                            OURSLER, MERRY - Mayo Clinicitem
                                            ZHANG, XINPING - University Of Rochesteritem
                                            VACHER, JEAN - University Of Montrealitem
                                            LI, CHUNYI - State University Of New York (SUNY)item
                                            YANG, SHUYING - State University Of New York (SUNY)item
                                            OLSON OLSON, DOUGLAS - New York University
  Submitted to: Cell Death and Differentiation
                                    Publication Type: Peer Reviewed Journal
                                    Publication Acceptance Date: 3/18/2015
                                    Publication  Date: 4/24/2015
                                    Publication URL: http://handle.nal.usda.gov/10113/61234Citation: Yuan, X., Cao, J.J., Liu, T., Li, Y., Scannapieco, F., He, X., Oursler, M.J., Zhang, X., Vacher, J., Li, C., Yang, S., Olson Olson, D. 2015. Regulators of G protein signaling 12 (Rgs12) promotes osteoclastogenesis in bone remodeling and pathologic bone loss. Cell Death and Differentiation. Available: http://www.nature.com/cdd/journal/vaop/ncurrent/full/cdd201545a.html.Interpretive Summary: Bone mass is regulated by the balance between bone forming cells, osteoblasts, and bone resorbing cells, osteoclasts. In osteoporosis condition, the balance shifts towards increased osteoclast activity. Regulator of G-protein signaling 12 (Rgs) has been found to play an important role in calcium signaling and osteoclast differentiation. Using a conditional Rgs-12 knockout mouse model, we demonstrated that Rgs-12 deficiency resulted in increased bone mass and decreased osteoclast differentiation, and function, and impaired calcium oscillations. Specific deletion of Rgs-12 in the osteoclast precursor cells inhibited osteoclastogenesis induced by ovariectomy. Our results demonstrate that Rgs-12 is a key regulator of bone resorption and can be used as a potential therapeutic target for osteoporosis treatment.
                                Technical Abstract: Calcium (Ca2+) signaling plays a pivotal role in controlling various cellular processes such as secretion, differentiation, proliferation, motility, and cell death through the release of Ca2+ from internal stores and entry from extracellular fluid. In bone, receptor activator of NF-kB ligand (RANKL) evokes intracellular Ca2+ oscillations, which trigger nuclear factor-activated T cells cytoplasmic 1 (NFAT2 or NFATc1) -responsive gene transcription and drives osteoclast (OC) differentiation. However, what protein(s) are involved in regulating Ca2+ oscillations during OC differentiation and function remain largely unidentified. Although our in vitro study demonstrated that regulator of G-protein signaling (Rgs) 12 plays crucial roles in Ca2+ oscillations and OC differentiation, how Rgs12 contributes to calcium signaling, OC differentiation and bone diseases has not been defined. We created a mouse model in which Rgs12 was specifically deleted in OC precursors in developmental and postnatal stages by crossing Rgs12 conditional knockout mice with CD11b-Cre and inducible Mx1-Cre transgenic mice. Rgs12-deficient mice displayed the phenotype of increased bone mass and decreased OC numbers. Deletion of Rgs12 blocked OC marker gene expression, and impaired OC differentiation and function, which were associated with decreased expression of NFAT2 and impaired Ca2+ oscillations. Ectopic expression of constitutive active NFAT2 (ca-NFAT2) in Rgs12-deficient OC precursor cells restored defective OC differentiation and function. To determine if bone resorption and turnover can be stimulated in the absence of Rgs12, Rgs12-deficient mice were subjected to ovariectomy and lipodysaccharide(LPS)-induction for bone loss in calvarial and alveolar bone. Specific deletion of Rgs12 in the OC precursor cells significantly inhibited pathologic osteoclastogenesis and bone destruction. Thus, our study demonstrates that Rgs12 is a key regulator of osteoclastogenesis through modulating the RANKL-Rgs12-Ca2+ oscillations-NFAT2 pathway and identifies Rgs12 as a potential therapeutic target for osteoporosis and inflammation-caused bone loss. 
Keywords: osteoclast, Rgs12, calcium oscillations, NFAT2


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov